Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Donald Bodenner

Concepts (247)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
14
2017
162
2.050
 Why?
Thyroidectomy
13
2019
103
1.900
 Why?
Parathyroidectomy
8
2018
75
1.360
 Why?
Thyroid Diseases
6
2019
36
1.340
 Why?
Parathyroid Neoplasms
5
2015
44
1.160
 Why?
Thyroid Gland
7
2017
93
1.110
 Why?
Vitamin D Deficiency
5
2019
53
1.020
 Why?
Adenoma
4
2017
142
1.000
 Why?
Parathyroid Hormone
8
2019
196
1.000
 Why?
Vitamin D
4
2015
101
0.880
 Why?
Fluorodeoxyglucose F18
6
2013
205
0.790
 Why?
Positron-Emission Tomography
7
2013
322
0.770
 Why?
Carcinoma, Papillary
4
2017
65
0.760
 Why?
Radiopharmaceuticals
7
2015
238
0.750
 Why?
Ambulatory Surgical Procedures
4
2014
52
0.750
 Why?
Hyperparathyroidism, Primary
4
2018
50
0.700
 Why?
Hyperparathyroidism
2
2015
50
0.630
 Why?
Iodine Radioisotopes
3
2015
43
0.610
 Why?
Megestrol Acetate
2
2007
17
0.580
 Why?
Parathyroid Diseases
2
2016
8
0.570
 Why?
Bone Density Conservation Agents
2
2007
83
0.550
 Why?
Nursing Homes
2
2007
126
0.540
 Why?
Incidental Findings
3
2013
42
0.520
 Why?
Proton Pump Inhibitors
1
2015
84
0.510
 Why?
Diphosphonates
1
2015
96
0.500
 Why?
Academic Medical Centers
2
2012
141
0.500
 Why?
Thyroglobulin
2
2013
11
0.490
 Why?
Carcinoma, Medullary
2
2010
15
0.470
 Why?
Parathyroid Glands
5
2018
39
0.460
 Why?
Aged
19
2017
10054
0.460
 Why?
Middle Aged
25
2017
13088
0.450
 Why?
Hypothyroidism
2
2011
53
0.430
 Why?
Retrospective Studies
14
2019
6432
0.400
 Why?
Male
31
2019
27334
0.400
 Why?
Calcitonin
2
2010
38
0.400
 Why?
Postoperative Complications
5
2018
1033
0.400
 Why?
Carcinoma
2
2012
153
0.370
 Why?
Humans
44
2019
54284
0.360
 Why?
Algorithms
1
2013
697
0.360
 Why?
Thyroid Nodule
3
2017
40
0.350
 Why?
Weight Loss
2
2009
271
0.330
 Why?
Female
29
2019
28441
0.330
 Why?
Appetite Stimulants
1
2007
5
0.310
 Why?
Cachexia
1
2007
24
0.300
 Why?
Teriparatide
1
2007
14
0.300
 Why?
Aged, 80 and over
9
2017
3431
0.290
 Why?
Four-Dimensional Computed Tomography
2
2017
31
0.280
 Why?
Pituitary Hormones, Anterior
1
2005
3
0.270
 Why?
Hypocalcemia
2
2016
13
0.270
 Why?
Phenylurea Compounds
2
2015
16
0.270
 Why?
Hormones
1
2005
59
0.270
 Why?
Calcium
3
2018
432
0.270
 Why?
Quinolines
2
2015
40
0.260
 Why?
Transcriptional Activation
1
2005
134
0.260
 Why?
Osteoporosis
1
2007
164
0.260
 Why?
Receptors, Estrogen
1
2005
131
0.260
 Why?
Pituitary Gland
1
2005
78
0.260
 Why?
Interleukin-6
1
2005
315
0.240
 Why?
NF-kappa B
1
2005
335
0.230
 Why?
Protein Kinase Inhibitors
2
2015
216
0.230
 Why?
Biopsy, Fine-Needle
5
2011
116
0.230
 Why?
Illinois
2
2013
15
0.220
 Why?
Treatment Outcome
8
2015
5604
0.210
 Why?
Adult
13
2017
14207
0.200
 Why?
Gene Expression Regulation
1
2005
1062
0.180
 Why?
Young Adult
7
2015
4318
0.180
 Why?
Aging
1
2005
784
0.180
 Why?
Follow-Up Studies
3
2013
2387
0.170
 Why?
Hyperparathyroidism, Secondary
1
2019
9
0.170
 Why?
Postoperative Period
3
2015
189
0.170
 Why?
Preoperative Care
2
2018
184
0.160
 Why?
Vitamins
2
2018
72
0.160
 Why?
Patient Discharge
3
2016
353
0.150
 Why?
Intraoperative Complications
1
2019
125
0.150
 Why?
Insulin Resistance
2
2009
300
0.140
 Why?
Prospective Studies
2
2013
2604
0.140
 Why?
United States
5
2015
5217
0.140
 Why?
Antineoplastic Agents
2
2015
1300
0.140
 Why?
Reoperation
1
2018
454
0.140
 Why?
Predictive Value of Tests
3
2015
1048
0.140
 Why?
Incidence
2
2011
1082
0.140
 Why?
Hypoparathyroidism
1
2015
11
0.130
 Why?
Carcinoma, Neuroendocrine
1
2015
27
0.130
 Why?
Creatinine
1
2015
169
0.130
 Why?
Adolescent
5
2015
6897
0.130
 Why?
Costs and Cost Analysis
2
2014
109
0.130
 Why?
Tomography, Emission-Computed, Single-Photon
1
2015
57
0.130
 Why?
Disease Progression
3
2015
913
0.130
 Why?
Lymph Nodes
1
2017
284
0.130
 Why?
Molecular Targeted Therapy
1
2015
128
0.120
 Why?
Ambulatory Care
1
2016
230
0.120
 Why?
Diagnosis, Differential
6
2018
1136
0.120
 Why?
Neoplasm Metastasis
2
2015
252
0.120
 Why?
Hospitals, University
1
2014
89
0.120
 Why?
Child, Preschool
2
2013
4147
0.120
 Why?
Sensitivity and Specificity
2
2013
923
0.110
 Why?
Exercise
2
2009
552
0.110
 Why?
Technetium
1
2012
10
0.110
 Why?
Hospitals, Teaching
1
2013
58
0.110
 Why?
Drug Administration Schedule
1
2013
401
0.110
 Why?
Liver
2
2009
1225
0.110
 Why?
Administration, Oral
1
2013
459
0.110
 Why?
Preoperative Period
1
2012
59
0.110
 Why?
Radionuclide Imaging
1
2012
130
0.110
 Why?
Outpatients
1
2013
123
0.110
 Why?
Hospital Charges
1
2012
50
0.110
 Why?
Patient Compliance
1
2013
249
0.110
 Why?
Struma Ovarii
1
2012
6
0.110
 Why?
Tumor Burden
1
2012
142
0.110
 Why?
Cost Savings
1
2012
67
0.100
 Why?
Clinical Competence
2
2018
446
0.100
 Why?
Ovariectomy
1
2012
125
0.100
 Why?
Prognosis
3
2015
2118
0.100
 Why?
Child
3
2013
7341
0.100
 Why?
Chromogranin A
1
2010
5
0.100
 Why?
Immunohistochemistry
2
2012
1089
0.100
 Why?
Obesity
2
2009
1202
0.090
 Why?
Radiation Monitoring
1
2010
8
0.090
 Why?
Checklist
1
2010
36
0.090
 Why?
Inpatients
1
2011
204
0.090
 Why?
Radiosurgery
1
2011
122
0.090
 Why?
Databases, Factual
1
2013
684
0.090
 Why?
Dose-Response Relationship, Drug
1
2013
1476
0.090
 Why?
Fatal Outcome
1
2010
225
0.090
 Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
6
0.090
 Why?
Caloric Restriction
1
2009
37
0.090
 Why?
Proto-Oncogene Proteins c-ret
1
2009
35
0.090
 Why?
Intra-Abdominal Fat
1
2009
22
0.090
 Why?
Ultrasonography
4
2015
480
0.090
 Why?
General Surgery
1
2010
113
0.080
 Why?
Occupational Exposure
1
2010
129
0.080
 Why?
Receptors, Thyrotropin
1
2007
7
0.080
 Why?
Symporters
1
2007
18
0.080
 Why?
Blastomycosis
1
2008
61
0.080
 Why?
Adenoma, Oxyphilic
1
2007
17
0.080
 Why?
Whole Body Imaging
1
2007
25
0.080
 Why?
Anorexia
1
2007
7
0.080
 Why?
Adiposity
1
2009
142
0.080
 Why?
Ovarian Neoplasms
1
2012
472
0.080
 Why?
Severity of Illness Index
1
2011
1084
0.070
 Why?
Calcifediol
1
2006
9
0.070
 Why?
DNA, Neoplasm
1
2007
171
0.070
 Why?
Calcium Carbonate
1
2006
11
0.070
 Why?
Practice Management, Medical
1
2006
13
0.070
 Why?
Medical Audit
1
2006
23
0.070
 Why?
Time Factors
3
2015
3213
0.070
 Why?
Drug Utilization Review
1
2006
26
0.070
 Why?
Promoter Regions, Genetic
2
2007
520
0.070
 Why?
Drug Monitoring
1
2006
85
0.070
 Why?
Head
1
2006
77
0.070
 Why?
Geriatrics
1
2006
47
0.070
 Why?
Body Mass Index
2
2009
713
0.070
 Why?
Otolaryngology
1
2006
58
0.070
 Why?
Cross-Sectional Studies
2
2014
1693
0.070
 Why?
Neck
1
2006
116
0.070
 Why?
Proportional Hazards Models
1
2007
431
0.070
 Why?
Progesterone Congeners
1
2005
5
0.070
 Why?
Gene Expression Regulation, Neoplastic
1
2010
866
0.070
 Why?
Body Fat Distribution
1
2005
11
0.070
 Why?
Freezing
1
2005
15
0.070
 Why?
Fractures, Bone
1
2006
119
0.070
 Why?
Faculty, Medical
1
2006
100
0.070
 Why?
Serum
1
2005
39
0.070
 Why?
Arkansas
2
2014
2100
0.070
 Why?
DNA Primers
1
2005
225
0.070
 Why?
Survival Analysis
1
2007
735
0.070
 Why?
HeLa Cells
1
2005
291
0.060
 Why?
Reproducibility of Results
3
2017
1304
0.060
 Why?
Internship and Residency
1
2010
501
0.060
 Why?
Base Sequence
1
2005
719
0.060
 Why?
Nuclear Proteins
1
2005
252
0.060
 Why?
Protein Binding
1
2005
736
0.060
 Why?
Infant
1
2012
3817
0.060
 Why?
ROC Curve
2
2015
259
0.060
 Why?
Intraoperative Period
2
2015
51
0.060
 Why?
Patient Selection
2
2018
286
0.060
 Why?
Randomized Controlled Trials as Topic
1
2005
596
0.050
 Why?
Tomography, X-Ray Computed
3
2012
1213
0.050
 Why?
Thalidomide
1
2002
397
0.040
 Why?
Glucagon
2
2009
34
0.040
 Why?
Cohort Studies
2
2015
1543
0.040
 Why?
Monitoring, Intraoperative
1
2019
66
0.040
 Why?
Cholecalciferol
1
2018
25
0.040
 Why?
Medical History Taking
1
2018
51
0.040
 Why?
Hospitals, High-Volume
1
2018
35
0.040
 Why?
Risk Factors
1
2006
3935
0.040
 Why?
Lymphatic System
1
2017
15
0.040
 Why?
Methylene Blue
1
2017
12
0.040
 Why?
Animals, Genetically Modified
1
2017
52
0.040
 Why?
Pilot Projects
2
2010
808
0.040
 Why?
Societies, Medical
1
2018
194
0.040
 Why?
Coloring Agents
1
2017
84
0.040
 Why?
Mice, Inbred Strains
1
2017
198
0.040
 Why?
Proto-Oncogene Proteins B-raf
1
2017
90
0.040
 Why?
Recurrence
1
2018
690
0.040
 Why?
Insulin
2
2009
510
0.040
 Why?
Lymphatic Metastasis
1
2017
256
0.030
 Why?
Bone Density
1
2018
416
0.030
 Why?
Brachial Plexus
1
2015
12
0.030
 Why?
Retreatment
1
2015
57
0.030
 Why?
Technetium Tc 99m Sestamibi
1
2015
29
0.030
 Why?
Endocrinology
1
2015
13
0.030
 Why?
Axilla
1
2015
101
0.030
 Why?
Hematoma
1
2015
60
0.030
 Why?
Transplantation, Autologous
1
2015
476
0.030
 Why?
Neoplasm Staging
1
2015
806
0.030
 Why?
Hernia, Abdominal
1
2012
6
0.030
 Why?
Activating Transcription Factor 1
1
2012
23
0.030
 Why?
Delayed Diagnosis
1
2012
25
0.030
 Why?
Mutation
1
2017
1501
0.020
 Why?
Ribs
1
2010
18
0.020
 Why?
Feasibility Studies
1
2011
398
0.020
 Why?
Thoracotomy
1
2010
37
0.020
 Why?
Mediastinal Neoplasms
1
2010
20
0.020
 Why?
Hypercalcemia
1
2010
36
0.020
 Why?
Neck Dissection
1
2010
43
0.020
 Why?
Gas Chromatography-Mass Spectrometry
1
2009
70
0.020
 Why?
Hospitalization
1
2014
705
0.020
 Why?
Octreotide
1
2009
13
0.020
 Why?
Glucose Tolerance Test
1
2009
67
0.020
 Why?
Prevalence
1
2012
1025
0.020
 Why?
Adiponectin
1
2009
76
0.020
 Why?
Absorptiometry, Photon
1
2009
174
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2009
314
0.020
 Why?
Postmenopause
1
2009
102
0.020
 Why?
Eye
1
2008
36
0.020
 Why?
Bone Neoplasms
1
2010
193
0.020
 Why?
Iodine
1
2007
12
0.020
 Why?
Methylation
1
2007
130
0.020
 Why?
Neoplasm Recurrence, Local
1
2011
644
0.020
 Why?
Current Procedural Terminology
1
2006
9
0.020
 Why?
Multiple Myeloma
1
2002
3035
0.020
 Why?
Body Weight
1
2009
578
0.020
 Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
 Why?
Overweight
1
2009
240
0.020
 Why?
Office Visits
1
2006
49
0.020
 Why?
Mice
1
2017
6413
0.020
 Why?
Polymerase Chain Reaction
1
2007
531
0.020
 Why?
Blood Glucose
1
2009
489
0.020
 Why?
Genetic Predisposition to Disease
1
2009
570
0.020
 Why?
Risk Assessment
1
2010
1361
0.020
 Why?
Lung
1
2008
507
0.020
 Why?
Muscle, Skeletal
1
2009
847
0.010
 Why?
Thyroid Function Tests
1
2002
25
0.010
 Why?
Thyrotropin
1
2002
46
0.010
 Why?
Animals
1
2017
14385
0.010
 Why?
Clinical Trials as Topic
1
2002
490
0.010
 Why?
Bodenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (247) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (26) people
_
Same Department Expand Description
Search Department